World Mitochondrial Disease Week 2022

World Mitochondrial Disease Week is an initiative of International Mito Patients (IMP). The purpose of the World Mitochondrial Disease Week is to raise awareness of mitochondrial disease (mito) on a global scale through educational, fundraising and advocacy activities. This year on 18 - 24 September.

Abliva participates in World Mitochondrial Disease Week through videos that will be focused on increasing the understanding of the community to rare disease development, and more specifically to the development of new therapies for primary mitochondrial diseases. Over the week, we will highlight the important role patients have played in informing our strategy, discuss Abliva’s efforts to treat mitochondrial disease patients with our two clinical stage compounds, KL1333 and NV354, and hear from a patient, Daniela Gallo, about her struggles with the disease. 

Starting 18 September, Abliva’s videos will be posted daily below.

18 Sep:  Introducing Mitochondrial “Mito” Disease

19 Sep:  Designing Therapies for Mito Disease, and Abliva’s NV354 (video from 2021)

20 Sep: Living with Mitochondrial Disease

21 Sep: Drug Development in Mito Disease, and Abliva’s KL1333

22 Sep: Abliva’s upcoming Phase 2/3 study with KL1333

23 Sep: A Patient-Centric Approach to Drug Development

24 Sep: Meet Adrian, father of Rebecca who suffers from a mitochondrial disease